The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome

Inclusion Criteria: * ≥ 3 criteria for metabolic syndrome National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III criteria) * Triglyceride (TG) \< 400 mg/dl and Low Density Lipoprotein-Cholesterol (LDL-C) 100 mg/dl to 190 mg/dl * Written informed consent for participating in the study Exclusion Criteria: * Severe renal disease or renal dysfunction * Chronic liver disease or liver function impairment * Inflammatory muscle dysfunction or findings of muscle problems * Severe cardiac failure Other protocol defined inclusion exclusion criteria may apply